OASIS PHARMACEUTICALS, LLC

Oasis Pharmaceuticals - GPCRs - Pepducin Technology - PAR2

LEXINGTON, United States · Founded 2015 · $1.8M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$1.8M
Last Round
$1000K GrantJan 2024

About

Oasis Pharmaceuticals is a clinical-stage biotech startup advancing Pepducin technology, which targets the intracellular surface of G-protein coupled receptors (GPCRs) including PAR2. The company is developing treatments for inflammatory, fibrotic, and metabolic disorders including MASH, IPF, and atopic dermatitis in collaboration with Tufts Medical Center.

Summary

OASIS PHARMACEUTICALS, LLC is a Biotech company based in LEXINGTON, United States, founded in 2015. It has raised $1.8M in total, most recently a $1000K Grant round in Jan 2024.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Funding History

No funding data available yet.

Know something? Help us improve our data.

Similar Companies